SCHEMBL4925693

SCHEMBL4925693

CC(O)C(NC(=O)c1cc2ccccc2[nH]1)C(=O)NO

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 2/20 0.56
▸ HSPA8 P11142 2/20 0.54
▸ HSPA2 P54652 2/20 0.54
▸ HSPA5 P11021 1/20 0.54
▸ HSPA9 P38646 1/20 0.54
▸ EGFR P00533 3/20 0.54
▸ PIK3CA P42336 3/20 0.54
▸ TAS1R3 Q7RTX0 1/20 0.54
▸ TAS1R1 Q7RTX1 1/20 0.54
▸ GAA P10253 3/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ LMNA P02545 3/20 0.52
▸ TP53 P04637 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ HPGD P15428 1/20 0.50
▸ CCKAR P32238 1/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2934549 0.83 DRD2 (0.56) DRD2HSPA8HSPA2HSPA5HSPA9
SCHEMBL2934545 0.83 TAS1R3 (0.53) DRD2HSPA8HSPA2HSPA5HSPA9
SCHEMBL2935765 0.82 TAS1R3 (0.57) DRD2HSPA8HSPA2HSPA5HSPA9
SCHEMBL15661047 0.81 DRD2 (0.63) DRD2HSPA8HSPA2HSPA5HSPA9
SCHEMBL15659943 0.81 DRD2 (0.63) DRD2HSPA8HSPA2HSPA5HSPA9
SCHEMBL16414231 0.81 DRD2 (0.63) DRD2HSPA8HSPA2HSPA5HSPA9
SCHEMBL29949076 0.81 DRD2 (0.68) DRD2EGFRPIK3CATAS1R3TAS1R1
SCHEMBL13753384 0.81 DRD2 (0.68) DRD2EGFRPIK3CATAS1R3TAS1R1
SCHEMBL6446972 0.80 HSPA5 (0.60) DRD2HSPA8HSPA2HSPA5HSPA9
SCHEMBL6446970 0.80 HSPA5 (0.60) DRD2HSPA8HSPA2HSPA5HSPA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 — — US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 DRD2 1883/4885HSPA8 619/4885HSPA2 786/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 DRD2 1779/4885HSPA8 525/4885HSPA2 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback